These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2684695)
21. [Melanoma, hormonal factors and pregnancy]. Avril MF Ann Dermatol Venereol; 1993; 120(12):919-25. PubMed ID: 8074359 [No Abstract] [Full Text] [Related]
22. [Prognosis-oriented therapy of malignant melanoma. New concepts]. Garbe C; Stadler R; Orfanos CE Hautarzt; 1986 Jul; 37(7):365-72. PubMed ID: 3744822 [TBL] [Abstract][Full Text] [Related]
23. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision. McKenna DB; Lee RJ; Prescott RJ; Doherty VR Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337 [TBL] [Abstract][Full Text] [Related]
24. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Hartgrink HH; Van de Velde CJ Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1311-2; author reply 1312. PubMed ID: 15279220 [No Abstract] [Full Text] [Related]
25. [Prognostic significance of regional metastasis of malignant melanoma]. Belli F; Leo E; Baldini MT; Bartoli C; Rovati M; Rovati L; Veronesi P G Ital Oncol; 1988; 8(3-4):116-8. PubMed ID: 3229782 [No Abstract] [Full Text] [Related]
26. The clinical features of malignant melanoma. Friedman RJ; Rigel DS Dermatol Clin; 1985 Apr; 3(2):271-83. PubMed ID: 3830490 [TBL] [Abstract][Full Text] [Related]
27. Significance of cell kinetic parameters in the prognosis of malignant melanoma: a review. Vereecken P; Laporte M; Heenen M J Cutan Pathol; 2007 Feb; 34(2):139-45. PubMed ID: 17244025 [TBL] [Abstract][Full Text] [Related]
28. Pathology of melanoma. Elder DE Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2308s-2311s. PubMed ID: 16609050 [TBL] [Abstract][Full Text] [Related]
29. Iatrogenic ulceration of melanoma is not of prognostic significance. Helm TN J Am Acad Dermatol; 2004 Mar; 50(3):487; author reply 487-8. PubMed ID: 14988706 [No Abstract] [Full Text] [Related]
30. [Relation between estrogen and progesterone receptors and response to hormone therapy]. Leclercq G; Paridaens R; Heuson JC Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700 [TBL] [Abstract][Full Text] [Related]
31. [Acral-lentiginous melanoma: the newest subgroup of malignant melanomas of the skin]. Panizzon R; Stieger M; Schüler G; Hardmeier T Schweiz Med Wochenschr; 1982 Apr; 112(17):612-8. PubMed ID: 7089511 [TBL] [Abstract][Full Text] [Related]
32. [Prognostic evaluation of malignant melanoma]. Schmoeckel C; Bockelbrink A; Bockelbrink H; Braun-Falco O Med Klin Prax; 1982 Sep; 77(19):50-1. PubMed ID: 7132900 [No Abstract] [Full Text] [Related]
33. Randomized trials in melanoma: an update. Eggermont AM Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225 [TBL] [Abstract][Full Text] [Related]
34. [Risk factors for lymph node metastasis in malignant melanoma]. Mussack T; Waldner H; Kharraz-Tavakol A Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332 [TBL] [Abstract][Full Text] [Related]
35. Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations. Rongioletti F; Smoller BR J Cutan Pathol; 2005 Oct; 32(9):589-603. PubMed ID: 16176296 [TBL] [Abstract][Full Text] [Related]